February 8, 2007Current Opinion in Internal Medicine
Aldosterone, mineralocorticoid receptors, and vascular inflammation
Key result
Mineralocorticoid receptor blockade reduces proteinuria and target organ damage in hypertensive, diabetic, and hyperlipidemic models, highlighting its clinical relevance for vascular remodeling.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Hypothesis-generating for cardiorenal protection; leaves open translation from models to human outcomes.
PICO
P
Population
Vascular inflammation and target organ damage
I
Intervention / Comparator
Mineralocorticoid receptor blockade
Aldosterone signaling contributes substantially to vascular remodeling and target organ damage, and its blockade offers protective effects across various disease models.
Cite This Study
Fiebeler et al. (2007) conducted a review in Vascular inflammation and target organ damage. Mineralocorticoid receptor blockade was evaluated. Mineralocorticoid receptor blockade reduces proteinuria and target organ damage in hypertensive, diabetic, and hyperlipidemic models, highlighting its clinical relevance for vascular remodeling.